ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

CMS Withholds Coverage of CT Colonography

May 15, 2009

Medicare Program: HCFA Expands Coverage Of Cancer Screening Methods

January 9, 1998